Lumosa Therapeutics Co., Ltd. announced the appointment of Hsin-Jung Lin as Member of the Audit Committee. Effective date May 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
183.5 TWD | -7.56% | -2.65% | +168.67% |
05-14 | Lumosa Therapeutics Co., Ltd. Announces the Change of Chairperson | CI |
05-14 | Lumosa Therapeutics Co., Ltd. Announces the Change in Juristic-Person Director Representative | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+168.67% | 1.01B | |
+7.52% | 111B | |
+11.38% | 106B | |
-12.64% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.58% | 16.81B | |
+37.41% | 12.54B | |
-23.95% | 8.09B |
- Stock Market
- Equities
- 6535 Stock
- News Lumosa Therapeutics Co., Ltd.
- Lumosa Therapeutics Co., Ltd. Appoints Hsin-Jung Lin as Member of the Audit Committee